ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases

Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint Neuro Maestro Brain Model Comparative Reproducibility Error Results Reproducibility error of Maestro (green), FreeSurfer 7.2 (blue) and manual segmentation (red) for common brain structures (left), and average over all structures (right). Bars represent range of measured relative volume difference. SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NE
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint

FDA Approves Eflornithine to Reduce Risk of Relapse in High-Risk Neuroblastoma

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases

ClearPoint Neuro wins FDA nod for ClearPoint 2.2 with Maestro Brain Modeling

New ClearPoint Neuro software wins FDA clearance

ClearPoint Neuro (CLPT) Stock Price, News & Analysis

SNN

FDA Approved vs. FDA Cleared: Understanding Medical Device Regulations - Neuro20

SNN

ClearPoint Neuro (CLPT) Gets FDA's Nod for New Software

INVESTOR INITIATIVES

SNN

SNN

ClearPoint's (CLPT) Prism System Favored by Latest Study

Our History

SNN